At UnionDerm, clinical research is at the core of our commitment to advancing dermatologic treatments. Our physicians are actively involved in investigating the latest technologies, injectable treatments, topical formulations, and energy-based devices to ensure our patients have access to the most innovative and effective solutions to dermatologic conditions. With a state-of-the-art research facility, a dedicated full-time research team, and over 50 successful clinical trials completed, UnionDerm is a leader in cosmetic and medical dermatology research.
A LEADING DERMATOLOGY RESEARCH CENTER
UnionDerm’s research department is known for its rigorous scientific approach, patient safety, and efficiency. We have successfully conducted over 50 clinical trials with no FDA audits to date, a testament to our meticulous protocols and compliance with regulatory standards.
Our full-time research team includes:
- Principal Investigator: Harvard-trained Dr. Anne Chapas, a board-certified dermatologist with over 20 years of clinical research experience
- Board-Certified Dermatologist Research Fellow
- Clinical Research Coordinator
- All research team members are HIPAA and Good Clinical Practice (GCP) certified, ensuring the highest level of compliance and patient safety.
STATE OF-THE-ART RESEARCH FACILITIES & TECHNOLOGY
Our dedicated research space is designed to support a broad range of clinical studies, providing:
- Private research treatment rooms for study procedures
- On-site laboratory for sample collection and processing
- Specialized photography and imaging rooms, equipped with high-resolution digital photography and advanced 3D imaging systems (Cherry Imaging, Canfield) to ensure standardized, precise study data
- Secure record storage to maintain confidentiality and compliance
- UnionDerm’s New York City location provides access to a diverse patient population, allowing us to conduct studies with a broad range of subjects, including Skin of Color patients and both male and female participants. Our robust patient recruitment infrastructure ensures that clinical trials are completed promptly and efficiently.
COMPREHENSIVE CLINICAL & LABORATORY CAPABILITIES
Our facility is fully equipped to conduct a wide range of dermatologic studies, with capabilities including:
- Blood sample collection and analysis
- Biopsy collection and processing
- Physical examinations and vital sign collection
- Urine pregnancy test analysis
- Investigational product storage in a calibrated, temperature-controlled environment
- We partner with leading laboratory facilities such as Columbia and Quest for biopsy and blood sample analysis, ensuring accurate and reliable research data. Additionally, our Principal Investigator’s affiliation with Mount Sinai provides prompt access to emergency medical care if needed.
EXPERTISE IN DERMATOLOGIC RESEARCH
UnionDerm’s research department has led scientific research clinical trials on various research topics such as in technical laser development, injectable fillers, neuromodulators (such as Botox and Dysport), photodynamic therapy fortherapyfor skin cancers, and topical pharmaceutical products. We also collaborate with industry leaders to test over-the-counter skincare products and assess their efficacy both as standalone treatments and in combination with dermatologic procedures.
Our longstanding relationship with independent Institutional Review Boards (IRBs) enables us to facilitate expedited reviews of study protocols, ensuring trials begin without unnecessary delays. Our staff is highly experienced in working with:
- Various IRBs and electronic data capture (EDC) systems
- Advanced clinical photography systems (Canfield)
- Cutting-edge 3D imaging technology (Cherry Imaging)
PARTNER WITH US OR PARTICIPATE IN A CLINICAL TRIAL
If you are interested in participating in a clinical trial or would like to collaborate with UnionDerm’s research team on an innovative dermatologic study, please contact us at:
With our unparalleled expertise, cutting-edge technology, and commitment to scientific advancement, UnionDerm continues to shape the future of dermatologic treatments while providing unparalleled patient care.
